The Rocher Group is committed to women's health with PREDILIFE

The Rocher Group, in partnership with PREDILIFE, offers a predictive assessment of breast cancer to its female employees over 40 years old. This partnership, announced on October 21, 2024, is part of a proactive approach for women's health. In France, breast cancer affects approximately one in eight women, representing the leading cause of cancer death among women.

Pink October, Breast Cancer Awareness Month, thus provides an ideal framework for this initiative. The Rocher Group is strengthening its commitment to the health of its employees with this innovative offer. Jeanne Renard, the group's People & Mission Director, emphasizes the importance of team health in HR policy. Stéphane Ragusa, CEO of PREDILIFE, underlines the shared mission of the two entities for the health of employees and customers.